Alexandra is a founding member and partner at Apollo Ventures, a biotech company builder and investment fund focused on developing interventions, that improve human health and longevity. At Apollo, Alexandra is leading the venture creation programs that aim at founding new biotech startups targeting the ageing process at a molecular level. She is also managing the pipeline and diligence process for external investment opportunities, predominantly focusing on preclinical stage biotech companies.
Before joining Apollo Ventures, Alexandra worked with The Boston Consulting Group where she specialised in biopharma strategy, market assessment and asset diligence. Her PhD studies at Harvard Medical School were focused on investigating the molecular mechanisms that contribute to cellular ageing and could be targeted to increase mammalian health span. She is also a licensed pharmacist with expertise in pharmaceutics and pharmacology.